Home > Investor Relations > Financials & Filings Financials & Filings Fourth Quarter 2017 Financial Results Show all 2017 Fourth Quarter NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs Fourth Quarter 2017 Earnings Conference Call Form 10-K Proxy Statements Filing date View Apr 9, 2018 View HTML 0001126234-18-000064.pdf 0001126234-18-000064.xls Mar 31, 2017 View HTML 0001126234-17-000030.pdf 0001126234-17-000030.xls Form 10-K Filing date View Mar 5, 2018 View HTML 0001126234-18-000026.pdf 0001126234-18-000026.xls Mar 6, 2017 View HTML 0001126234-17-000025.pdf 0001126234-17-000025.xls Form 10-Q Filing date View Nov 3, 2017 View HTML 0001126234-17-000107.pdf 0001126234-17-000107.xls Aug 3, 2017 View HTML 0001126234-17-000081.pdf 0001126234-17-000081.xls Facebook Google LinkedIn Twitter RSS
Financials & Filings Fourth Quarter 2017 Financial Results Show all 2017 Fourth Quarter NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs Fourth Quarter 2017 Earnings Conference Call Form 10-K Proxy Statements Filing date View Apr 9, 2018 View HTML 0001126234-18-000064.pdf 0001126234-18-000064.xls Mar 31, 2017 View HTML 0001126234-17-000030.pdf 0001126234-17-000030.xls Form 10-K Filing date View Mar 5, 2018 View HTML 0001126234-18-000026.pdf 0001126234-18-000026.xls Mar 6, 2017 View HTML 0001126234-17-000025.pdf 0001126234-17-000025.xls Form 10-Q Filing date View Nov 3, 2017 View HTML 0001126234-17-000107.pdf 0001126234-17-000107.xls Aug 3, 2017 View HTML 0001126234-17-000081.pdf 0001126234-17-000081.xls
Contact us
Contact us